Logo image of JBLU

JETBLUE AIRWAYS CORP (JBLU) Stock Fundamental Analysis

NASDAQ:JBLU - Nasdaq - US4771431016 - Common Stock - Currency: USD

3.67  +0.25 (+7.15%)

After market: 3.65 -0.02 (-0.54%)

Fundamental Rating

2

Taking everything into account, JBLU scores 2 out of 10 in our fundamental rating. JBLU was compared to 23 industry peers in the Passenger Airlines industry. JBLU has a bad profitability rating. Also its financial health evaluation is rather negative. JBLU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year JBLU has reported negative net income.
In the past year JBLU had a positive cash flow from operations.
JBLU had negative earnings in each of the past 5 years.
JBLU had a positive operating cash flow in 4 of the past 5 years.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

JBLU has a Return On Assets (-4.72%) which is in line with its industry peers.
JBLU has a Return On Equity (-30.10%) which is in line with its industry peers.
Industry RankSector Rank
ROA -4.72%
ROE -30.1%
ROIC N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

JBLU has a better Gross Margin (66.66%) than 86.96% of its industry peers.
JBLU's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for JBLU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
JBLU has more shares outstanding than it did 1 year ago.
The number of shares outstanding for JBLU has been increased compared to 5 years ago.
Compared to 1 year ago, JBLU has a worse debt to assets ratio.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

JBLU has an Altman-Z score of 0.72. This is a bad value and indicates that JBLU is not financially healthy and even has some risk of bankruptcy.
JBLU's Altman-Z score of 0.72 is in line compared to the rest of the industry. JBLU outperforms 43.48% of its industry peers.
JBLU has a Debt/Equity ratio of 3.08. This is a high value indicating a heavy dependency on external financing.
JBLU has a Debt to Equity ratio (3.08) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 3.08
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACCN/A
WACC4.91%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

JBLU has a Current Ratio of 1.10. This is a normal value and indicates that JBLU is financially healthy and should not expect problems in meeting its short term obligations.
JBLU has a Current ratio of 1.10. This is amongst the best in the industry. JBLU outperforms 86.96% of its industry peers.
JBLU has a Quick Ratio of 1.06. This is a normal value and indicates that JBLU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.06, JBLU belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.06
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for JBLU have decreased strongly by -53.19% in the last year.
JBLU shows a decrease in Revenue. In the last year, the revenue decreased by -3.50%.
The Revenue has been growing slightly by 2.77% on average over the past years.
EPS 1Y (TTM)-53.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.53%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-2.06%

3.2 Future

JBLU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.55% yearly.
The Revenue is expected to grow by 5.03% on average over the next years.
EPS Next Y-5.39%
EPS Next 2Y29.01%
EPS Next 3Y29.55%
EPS Next 5YN/A
Revenue Next Year2.7%
Revenue Next 2Y4.51%
Revenue Next 3Y5.03%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

JBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year JBLU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as JBLU.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.08
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as JBLU's earnings are expected to grow with 29.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.01%
EPS Next 3Y29.55%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for JBLU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (4/17/2025, 8:00:02 PM)

After market: 3.65 -0.02 (-0.54%)

3.67

+0.25 (+7.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)04-29 2025-04-29/bmo
Inst Owners90.63%
Inst Owner Change0%
Ins Owners10.18%
Ins Owner Change10.86%
Market Cap1.30B
Analysts49.09
Price Target6.27 (70.84%)
Short Float %16.67%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.88%
Min EPS beat(2)33.81%
Max EPS beat(2)37.94%
EPS beat(4)4
Avg EPS beat(4)64.95%
Min EPS beat(4)18.47%
Max EPS beat(4)169.56%
EPS beat(8)6
Avg EPS beat(8)31.59%
EPS beat(12)8
Avg EPS beat(12)-4.96%
EPS beat(16)12
Avg EPS beat(16)0.72%
Revenue beat(2)0
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-0.96%
Max Revenue beat(2)-0.88%
Revenue beat(4)0
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)-0.74%
Revenue beat(8)0
Avg Revenue beat(8)-1.39%
Revenue beat(12)0
Avg Revenue beat(12)-1.61%
Revenue beat(16)3
Avg Revenue beat(16)-0.82%
PT rev (1m)1.07%
PT rev (3m)-2.97%
EPS NQ rev (1m)-0.67%
EPS NQ rev (3m)-34.54%
EPS NY rev (1m)-20.91%
EPS NY rev (3m)-19.91%
Revenue NQ rev (1m)-0.86%
Revenue NQ rev (3m)-2.74%
Revenue NY rev (1m)-2.37%
Revenue NY rev (3m)-2.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF 9.03
P/B 0.49
P/tB 0.58
EV/EBITDA 8.08
EPS(TTM)-0.72
EYN/A
EPS(NY)-0.76
Fwd EYN/A
FCF(TTM)-4.16
FCFYN/A
OCF(TTM)0.41
OCFY11.07%
SpS26.19
BVpS7.45
TBVpS6.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.72%
ROE -30.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.66%
FCFM N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 3.08
Debt/FCF N/A
Debt/EBITDA 14.5
Cap/Depr 247.18%
Cap/Sales 17.45%
Interest Coverage N/A
Cash Conversion 25.62%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.06
Altman-Z 0.72
F-Score4
WACC4.91%
ROIC/WACCN/A
Cap/Depr(3y)199.72%
Cap/Depr(5y)186.25%
Cap/Sales(3y)13.36%
Cap/Sales(5y)16.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.53%
EPS Next Y-5.39%
EPS Next 2Y29.01%
EPS Next 3Y29.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-2.06%
Revenue Next Year2.7%
Revenue Next 2Y4.51%
Revenue Next 3Y5.03%
Revenue Next 5YN/A
EBIT growth 1Y-190.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year472.9%
EBIT Next 3Y99.39%
EBIT Next 5YN/A
FCF growth 1Y-83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64%
OCF growth 3Y-55.57%
OCF growth 5Y-36.98%